Associate Professor Pamela Lutsey found that DOAC drugs appear to be just as safe to use as heparin and warfarin for treating venous thromboembolism in cancer patients.
venous thromboembolism
Understanding Patient Drug Preferences for Treating Venous Thromboembolism
Research by Associate Professor Pamela Lutsey found that patients viewed the reversibility of an anticoagulant and the ability to monitor its levels as important.
